| Name
|
Angiotensin II, human
|
| Code
|
[4474-91-3]
|
| The alias
|
Angiotensin II, human
|
| Sequence (single letter abbreviation)
|
DRVYIHPF
|
| Sequence (three-letter abbreviation)
|
H-Asp-Arg-Val-Tyr-Ile-His-Pro-Phe-OH (trifluoroacetate salt)
|
| A basic description
|
"Anti-angiotensin II" peptide deduced from the antisense mRNA complementary to the human angiotensin II mRNA. The sequence of this octapeptide is 50% homologous to angiotensin II but functions as an antagonist of angiotensin II, causing uterine contractions and hypertensive responses in rats.
|
| solubility
|
|
| The molecular weight
|
1046.2
|
| Chemical formula
|
C50H71N13O12
|
| The purity
|
80%，90%，95%，98%，99%
|
| Weight
|
1mg,5mg,10mg,50mg,100mg,1g
|
| Storage conditions
|
Store at -20°C. Keep tightly closed. Store in a cool dry place.
|
| Annotation
|
|
| Documents
|
|
| Figures
|
|
| Reference
|
A.W.A. Hahn et al., J. Cardiovasc. Pharmacol., 22 (Suppl.5), S37 (1993)
T. Inagami et al., Cardiovase. Drugs Ther., 2, 453 (1988)
|
| The C-terminal
|
|
| The N-terminal
|
|
| Chemical bridge
|
|